The Food and Drug Administration (FDA) has expanded the approval of Baqsimi (glucagon) nasal powder to include the treatment of severe hypoglycemia in ...

Venxxiva ™ (tiopronin delayed-release tablet) has been made available for the treatment of cystinuria.

The Food and Drug Administration (FDA) has approved Arbli™, an oral suspension formulation of losartan potassium.  Arbli, an angiotensin II receptor ...

Vimkunya™ (chikungunya vaccine, recombinant) is now available in the US for the prevention of disease caused by chikungunya virus in individuals 12 years ...

Optimizing copper, manganese, and vitamin B12 during pregnancy can help lower the risk for high blood pressure and hypertension in midlife, according to a study published online March 6 in ...

However, white wine significantly associated with increased risk for cancer among women and in analyses restricted to cohort studies.

The active ingredient in Zunveyl is benzgalantamine, a prodrug of galantamine, a competitive and reversible inhibitor of actylcholinesterase.

The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental New Drug Application (sNDA) for finerenone for the treatment of ...

Moderate reduction in OB/GYN practitioners seen in states that adopted restrictive abortion laws versus control states ...

Rebounds seen in breast cancer and colonoscopy screening, while reported cervical cancer screening in 2023 remained below 2019 estimates ...

HealthDay News — The US Food and Drug Administration is cautioning consumers against the recreational use of any flavor of nitrous oxide (also known as laughing gas) from canisters, tanks, or chargers ...

Daridorexant, a dual orexin receptor antagonist, is currently approved for the treatment of adult patients with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance.